SCHEMBL2297994

SCHEMBL2297994

C=C(CBr)c1ccc(Br)cc1

nearest known ligand 0.64

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GSK3B P49841 4/20 0.54
MAOA P21397 1/20 0.44
MAOB P27338 1/20 0.44
CES2 O00748 1/20 0.44
CES1 P23141 1/20 0.44
OGG1 O15527 1/20 0.41
CA1 P00915 2/20 0.41
CA2 P00918 2/20 0.41
CYP2A6 P11509 1/20 0.40
HDAC3 O15379 1/20 0.40
HDAC4 P56524 1/20 0.40
HDAC1 Q13547 1/20 0.40
HDAC7 Q8WUI4 1/20 0.40
HDAC2 Q92769 1/20 0.40
HDAC10 Q969S8 1/20 0.40
HDAC11 Q96DB2 1/20 0.40
HDAC8 Q9BY41 1/20 0.40
HDAC6 Q9UBN7 1/20 0.40
HDAC9 Q9UKV0 1/20 0.40
HDAC5 Q9UQL6 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20146334 0.82 GSK3B (0.45) GSK3BMAOAMAOB
SCHEMBL12318444 0.80 PTPN1 (0.54) CA1CA2ALOX15ALDH1A1
SCHEMBL2175225 0.78 PTPN1 (0.56) MAOAMAOBCES2CES1CA1
SCHEMBL5178198 0.78 MAOA (0.47) GSK3BMAOAMAOBCES2CES1
SCHEMBL13261924 0.78 MAOA (0.43) GSK3BMAOAMAOBCES2CES1
SCHEMBL991358 0.78 GSK3B (0.56) GSK3BMAOAMAOBCES2CES1
SCHEMBL250821 0.77 PTPN1 (0.52) GSK3BMAOAMAOBCES2CES1
SCHEMBL20716158 0.75 ALDH1A1 (0.48) GSK3BCYP2A6ALDH1A1
SCHEMBL13963146 0.75 PTPN1 (0.59) GSK3BMAOAMAOBALDH1A1
SCHEMBL5134898 0.75 MAOA (0.41) GSK3BMAOAMAOBCES2CES1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3438106-A1 ANTI-VIRAL COMPOUNDS AbbVie Ireland Unlimited Company (IE) 2019-02-06 EP disclosed
WO-2011103063-A1 THERAPEUTIC COMPOUNDS GLAXO GROUP LIMITED (GB) 2011-08-25 WO disclosed